Jane Street’s Maravai LifeSciences MRVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.63M Buy
1,636,145
+341,087
+26% +$1.16M ﹤0.01% 3638
2025
Q4
$4.21M Buy
1,295,058
+741,537
+134% +$2.5M ﹤0.01% 3505
2025
Q3
$1.59M Buy
553,521
+481,032
+664% +$1.23M ﹤0.01% 5370
2025
Q2
$175K Sell
72,489
-307,914
-81% -$647K ﹤0.01% 8641
2025
Q1
$841K Buy
380,403
+356,067
+1,463% +$1.41M ﹤0.01% 5896
2024
Q4
$133K Sell
24,336
-46,754
-66% -$301K ﹤0.01% 8632
2024
Q3
$591K Sell
71,090
-201,787
-74% -$1.74M ﹤0.01% 6906
2024
Q2
$1.95M Sell
272,877
-213,329
-44% -$1.84M ﹤0.01% 4522
2024
Q1
$4.22M Buy
486,206
+178,565
+58% +$1.21M ﹤0.01% 2878
2023
Q4
$2.02M Buy
307,641
+241,319
+364% +$1.56M ﹤0.01% 4307
2023
Q3
$663K Sell
66,322
-179,967
-73% -$1.98M ﹤0.01% 5818
2023
Q2
$3.06M Buy
246,289
+220,846
+868% +$2.98M ﹤0.01% 3459
2023
Q1
$356K Sell
25,443
-176,878
-87% -$2.54M ﹤0.01% 6902
2022
Q4
$2.9M Buy
+202,321
New +$3.19M ﹤0.01% 3277
2022
Q3
Sell
-38,554
Closed -$967K 10164
2022
Q2
$1.1M Sell
38,554
-64,039
-62% -$2.03M ﹤0.01% 5325
2022
Q1
$3.62M Buy
102,593
+19,620
+24% +$658K ﹤0.01% 3600
2021
Q4
$3.48M Buy
+82,973
New +$3.36M ﹤0.01% 3443
2021
Q3
Sell
-79,710
Closed -$3.89M 10432
2021
Q2
$3.33M Buy
79,710
+63,240
+384% +$2.45M ﹤0.01% 3394
2021
Q1
$587K Sell
16,470
-42,280
-72% -$1.4M ﹤0.01% 6516
2020
Q4
$1.65M Buy
+58,750
New +$1.64M ﹤0.01% 3842

Other funds holding MRVI

Jane Street's MRVI Position: Q1 2026 in Review

Jane Street increased its Maravai LifeSciences (MRVI) stake by 26% in Q1 2026, buying an estimated $1.16M and bringing the position to 1,636,145 shares worth $4.63M. The position accounts for ﹤0.01% of the portfolio, ranked #3638.

Jane Street first reported a position in MRVI in Q4 2020 and has held it in 20 quarters since. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

  • Jane Street held 1,636,145 shares of Maravai LifeSciences worth $4.63M as of Q1 2026.
  • Jane Street bought 341,087 Maravai LifeSciences shares in Q1 2026, an estimated $1.16M.
  • Maravai LifeSciences made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #3638 holding.
  • Jane Street first reported a position in Maravai LifeSciences in Q4 2020 and has held it in 20 quarters since.
  • 158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.